Marex Group plc Invests $395,000 in Arteris, Inc. $AIP

Marex Group plc acquired a new stake in shares of Arteris, Inc. (NASDAQ:AIPFree Report) in the 2nd quarter, Holdings Channel reports. The institutional investor acquired 41,500 shares of the company’s stock, valued at approximately $395,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Acadian Asset Management LLC grew its holdings in shares of Arteris by 40.6% during the first quarter. Acadian Asset Management LLC now owns 900,723 shares of the company’s stock worth $6,222,000 after purchasing an additional 260,277 shares in the last quarter. Acuitas Investments LLC bought a new position in shares of Arteris in the 2nd quarter worth $858,000. Worth Venture Partners LLC purchased a new stake in shares of Arteris during the 2nd quarter valued at $451,000. Franklin Resources Inc. lifted its holdings in shares of Arteris by 9.6% during the 2nd quarter. Franklin Resources Inc. now owns 1,637,171 shares of the company’s stock worth $15,602,000 after acquiring an additional 142,936 shares during the last quarter. Finally, Campbell & CO Investment Adviser LLC purchased a new position in Arteris in the second quarter worth $254,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Insiders Place Their Bets

In related news, CEO K Charles Janac sold 70,000 shares of Arteris stock in a transaction on Monday, December 8th. The shares were sold at an average price of $17.71, for a total value of $1,239,700.00. Following the sale, the chief executive officer owned 9,469,071 shares in the company, valued at $167,697,247.41. The trade was a 0.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Laurent R. Moll sold 17,937 shares of the company’s stock in a transaction on Monday, December 8th. The stock was sold at an average price of $17.92, for a total transaction of $321,431.04. Following the completion of the transaction, the chief operating officer owned 257,222 shares of the company’s stock, valued at $4,609,418.24. This trade represents a 6.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 820,825 shares of company stock worth $12,276,775. Insiders own 33.70% of the company’s stock.

Wall Street Analyst Weigh In

AIP has been the subject of several research analyst reports. Wall Street Zen raised Arteris from a “sell” rating to a “hold” rating in a research note on Monday, September 15th. Cowen reaffirmed a “buy” rating on shares of Arteris in a research note on Wednesday, November 5th. Jefferies Financial Group raised shares of Arteris to a “hold” rating in a research note on Tuesday, October 28th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arteris in a report on Wednesday, October 8th. Finally, Rosenblatt Securities reiterated a “buy” rating and issued a $20.00 target price on shares of Arteris in a research report on Monday. Four investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Arteris has a consensus rating of “Moderate Buy” and a consensus price target of $17.50.

Check Out Our Latest Research Report on AIP

Arteris Trading Down 2.2%

Shares of NASDAQ:AIP opened at $15.93 on Tuesday. The company has a 50-day moving average price of $14.44 and a 200-day moving average price of $11.15. The company has a market cap of $695.82 million, a price-to-earnings ratio of -19.19 and a beta of 1.48. Arteris, Inc. has a 12 month low of $5.46 and a 12 month high of $19.85.

Arteris (NASDAQ:AIPGet Free Report) last announced its quarterly earnings results on Tuesday, November 4th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.02. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.25%.The company had revenue of $17.41 million for the quarter, compared to the consensus estimate of $17.00 million. As a group, research analysts forecast that Arteris, Inc. will post -0.73 EPS for the current fiscal year.

About Arteris

(Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Recommended Stories

Want to see what other hedge funds are holding AIP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arteris, Inc. (NASDAQ:AIPFree Report).

Institutional Ownership by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.